Press Releases
Webster Committed to Finding Cures
July 10, 2015
(Washington, DC) – Representative Daniel Webster (FL-10) issued the following statement today after voting in support of the overwhelmingly bipartisan H.R. 6, the 21st Century Cures Act, of which he is also a co-sponsor:
“Each of us has family or friends who suffer from major health issues. It is hard to see a child struggle with a tragic disease or to watch a loved one receive a diagnosis for which there seems to be more questions than answers. Today, I voted in support of the bipartisan 21st Century Cures Act in order to find answers.
“This legislation not only focuses and increases funding for the National Institutes of Health, but provides grants to our best and brightest researchers who are most likely to discover cures and promising therapies. The 21st Century Cures Act provides incentives, streamlines research review, modernizes clinical trials, and fosters an innovative approach to treat diseases and medical conditions. America can and must remain the biomedical innovation capital of the world and this bill allocates the resources and removes the bureaucratic hurdles necessary to ensure we do.”
Background:
Medical professionals have identified over 10,000 diseases and health conditions, but we only have the cures and treatments for about 500 of them. The NIH estimates that the development of a new drug takes on average 14 years and $2 billion.
“Each of us has family or friends who suffer from major health issues. It is hard to see a child struggle with a tragic disease or to watch a loved one receive a diagnosis for which there seems to be more questions than answers. Today, I voted in support of the bipartisan 21st Century Cures Act in order to find answers.
“This legislation not only focuses and increases funding for the National Institutes of Health, but provides grants to our best and brightest researchers who are most likely to discover cures and promising therapies. The 21st Century Cures Act provides incentives, streamlines research review, modernizes clinical trials, and fosters an innovative approach to treat diseases and medical conditions. America can and must remain the biomedical innovation capital of the world and this bill allocates the resources and removes the bureaucratic hurdles necessary to ensure we do.”
Background:
Medical professionals have identified over 10,000 diseases and health conditions, but we only have the cures and treatments for about 500 of them. The NIH estimates that the development of a new drug takes on average 14 years and $2 billion.
###